{
    "organizations": [],
    "uuid": "343ce71173ec5a3c08ecd81168c53ddabfb14dd0",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-aradigm-announces-ema-has-complete/brief-aradigm-announces-ema-has-completed-its-validation-of-the-maa-submission-idUSFWN1RI0F0",
    "ord_in_thread": 0,
    "title": "BRIEF-Aradigm Announces EMA Has Completed Its Validation Of The MAA Submission",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 5 (Reuters) - Aradigm Corp:\n* ARADIGM ANNOUNCES THE EMA HAS COMPLETED ITS VALIDATION OF THE MAA SUBMISSION\n* OPINION OF COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) FOR LINHALIQ EXPECTED WITHIN 210 DAYSâ€‹ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-05T20:13:00.000+03:00",
    "crawled": "2018-04-06T22:09:54.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "aradigm",
        "corp",
        "aradigm",
        "announces",
        "ema",
        "completed",
        "validation",
        "maa",
        "submission",
        "opinion",
        "committee",
        "medicinal",
        "product",
        "human",
        "use",
        "chmp",
        "linhaliq",
        "expected",
        "within",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}